Go Life International Limited

Go Life International Limited

GLI.JO
Go Life International LimitedZA flagJohannesburg Stock Exchange
1.00
ZAc
- -
- -
227.56MMarket Cap
Go Life International Limited
GLI.JO
(Johannesburg Stock Exchange)

Recent

price

1.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
-0.04
-0.04
- -
- -
- -
-0.04
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.1
0.06
0.02
0.01
0.04
0.04
- -
- -
-0.02
-0.03
-0.02
-0.02
-0.02
Book Value per Share
- -
0.1
0.05
0.01
0.01
0.01
0.04
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
97
97
97
97
900
900
900
900
900
768
1,242
1,242
1,242
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
2
2
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
54.67
- -
- -
- -
- -
- -
25.82
27.88
40.23
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-4
-4
- -
1
- -
-35
- -
- -
- -
- -
1
1
Net Income, GAAP
- -
- -
- -
- -
- -
15.55
- -
- -
- -
- -
- -
- -
27.24
21.88
Effective Tax Rate (%)
- -
- -
- -
- -
- -
31.63
- -
- -
- -
- -
- -
26.04
71.94
57.05
Profit Margin (%)
- -
- -
- -
- -
- -
1
- -
-1
- -
- -
- -
- -
1
1
Working Capital
- -
- -
- -
- -
- -
3
- -
- -
- -
- -
- -
- -
4
4
LT Debt
10
10
5
1
1
34
35
-1
- -
- -
- -
- -
-2
-2
Total Equity
- -
- -
- -
- -
- -
4.26
- -
- -
- -
- -
- -
- -
35.34
51.84
Return on Invested Capital (%)
- -
- -
- -
- -
- -
4.28
- -
- -
- -
- -
- -
-0.1
-11.96
-7.01
Return on Capital (%)
- -
-3.91
-56.84
-99.94
7.71
3.21
-0.2
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Aug'25
Nov'25
May'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
932
932
932
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Aug'25
Nov'25
May'26
Total Current Assets
- -
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
1
1
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
340.85%
237.4%
1,255.49%
Free Cash Flow
- -
- -
15,693.68%
Net Income, GAAP
5,517.83%
1,055.94%
5,533.4%
Sales/Revenue/Turnover
- -
- -
1,939.22%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
1
2
2026
1
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Numeral Limited, formerly Go Life International Limited, is an investment holding company primarily focused on the financial services sector, with interests in biotechnology, nutraceuticals, and health-related investments. Incorporated in 2010 and headquartered in Port Louis, Mauritius, the company maintains a primary listing on the Stock Exchange of Mauritius (GOLI.N0000) and a secondary listing on the JSE AltX (GLI). It holds investments including a recovered 50% stake in Cryo-Save South Africa Proprietary Limited, a stem cell banking entity; nutraceutical operations through legacy brands like Go Life Health Products and Gotha Health Products distributed via pharmacies and chain stores in South Africa; and biotechnology assets previously linked to frail care and property holdings via subsidiaries such as Bon Health Frail Care and Bon Health Properties. Operations span Mauritius, South Africa, and global nutraceutical markets, targeting healthcare providers, pharmacies, and individual consumers. In recent developments, the company changed its name to Numeral Limited in late 2023 to reflect a strategic pivot toward financial services, technology platforms, and investment banking opportunities; appointed LTS Management Services Limited as its management company, secretary, and registry provider in November 2023; announced terms in 2024 to acquire a 51% stake in Longevity Lab Proprietary Limited to bolster its biotechnology portfolio; and issued unaudited financial results for the six months ended 31 August 2024 showing ongoing recapitalization and group rebuilding efforts.